HD2A RASC-Research and Evaluation Core

HD2A RASC-研究和评估核心

基本信息

批准号：
10708989
负责人：
C. HENDRICKS BROWN
金额：
$ 102.4万
依托单位：
STANFORD UNIVERSITY
依托单位国家：
美国
项目类别：
财政年份：
2022
资助国家：
美国
起止时间：
2022-09-30 至 2027-08-31
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10708989
关键词：
Address Adoption African American Area COVID-19 Complex Core Assembly Data Data Collection Data Reporting Decision Making Disparity Dissemination and Implementation Economics Equity Evaluation Evaluation Reports Evidence based intervention Evidence based practice Future Goals Harm Reduction Health Benefit Insurance Coverage Intervention Interview Investments Knowledge Learning Measurement Measures Methodology Methods Modeling Monitor Motivation Pain Persons Phase Policies Primary Prevention Public Health Qualifying Recovery Support Reporting Research Research Methodology Research Project Grants Resource-limited setting Resources Role Science Scientist Standardization Substance Use Disorder Surveys System Testing Translational Research United States National Institutes of Health Work addiction career contextual factors data harmonization data infrastructure design dissemination science ethnic minority evaluation/testing experience formative assessment implementation barriers implementation evaluation implementation outcomes implementation research implementation science implementation strategy innovation insight male marginalized population medication for opioid use disorder models and simulation mortality multidisciplinary opioid use disorder overdose death programs racial minority scale up screening stimulant use disorder substance use text searching tool

项目摘要

RESEARCH AND EVALUATION CORE: PROJECT SUMMARY/ABSTRACT Although effective primary prevention, harm reduction, treatment, and recovery support interventions for substance use disorders and pain exist, they are not widely available. Crosscutting dissemination and implementation (D&I) scientific methods are required to select and deliver effective and efficient implementation strategies under variable contexts. The Research Adoption Support Center’s Research and Evaluation (R&E) Core, in concert with the Administrative, Substance Use Disorder Implementation Support (SUD-IS) and Pain Implementation Support (Pain-IS) cores, utilizes an integrated, multidisciplinary, iterative approach to provide rapid assessment, expert technical assistance, and advance the long-term adoption and sustainment of evidence-based interventions. The overarching goal of the R&E Core is to elevate the D&I capability and translational long-term impact of the HD2A Innovation Projects. We achieve this via standardized baseline information and on-demand support for data, analytic, and research translation needs, all toward leveraging sustainable change through science-based financing and policies. We will provide state- of-the art methodological support in D&I measurement, frameworks, modeling, and testing/evaluation, guided by R&E Core experts who have conducted extensive work across the four HHS pillars. Aligned with other RASC cores, we are guided by 3 dynamic phases: 1) ASSESS Innovation Projects’ baseline D&I capacity via 3 methods; 2) ASSIST the Innovation Projects in increasing D&I capability, while supporting harmonized data collection and reporting across projects; and, 3) ADVANCE Innovation Projects’ potential for sustainment and scale-up, and serve as the D&I research methodology resource to the HD2A Modeling and Economic Resource Center (MERC) and Data Infrastructure Support Center (DISC). A key function of the R&E core is the formative evaluation, a phased evaluation that will incorporate lessons learned within and across HD2A grantees, with formative evaluation reports (Years 1, 3) focused on providing insight to support timely decision- making and course corrections by grantees and NIH, and a final report (Year 5) focused on informing future initiatives of this kind. We also will conduct 5 Rapid Turnaround Research Projects designed to produce knowledge to address persistent or emerging barriers to implementation or sustainment identified by HD2A grantees. The Year 1 project will focus on the role of insurance coverage and other financing and reimbursement barriers to the widespread adoption of medications for opioid use disorder (MOUD). Within and beyond the HD2A program, we boldly seek to contribute knowledge and methods to the addiction and pain intervention fields with the ultimate goal of transformational and equitable public health benefit.

研究和评估核心：项目摘要/摘要尽管有效的初级预防、减少伤害、治疗和康复支持干预措施物质使用障碍和疼痛是存在的，但它们并未广泛传播和传播。实施 (D&I) 需要科学方法来选择和提供有效且高效的服务研究采用支持中心的研究和实施策略。评估 (R&E) 核心，与行政、药物滥用障碍实施支持相配合 (SUD-IS) 和疼痛实施支持 (Pain-IS) 核心，利用集成的、多学科的、迭代的提供快速评估、专家技术援助并推动长期采用和 R&E 核心的总体目标是提升 D&I。 HD2A 创新项目的能力和转化长期影响是通过我们实现的。标准化基线信息和对数据、分析和研究翻译需求的按需支持，一切都是为了通过基于科学的融资和政策来利用可持续变革。 D&I 测量、框架、建模和测试/评估方面最先进的方法论支持，指导由 R&E 核心专家负责，他们在 HHS 的四大支柱领域开展了广泛的工作，并与其他部门保持一致。 RASC 核心，我们以 3 个动态阶段为指导：1) 通过 3 个阶段评估创新项目的基准 D&I 能力 2) 协助创新项目提高 D&I 能力，同时支持统一数据跨项目的收集和报告；以及，3) ADVANCE 创新项目的维持和潜力扩大规模，并作为 HD2A 建模和经济的 D&I 研究方法资源资源中心 (MERC) 和数据基础设施支持中心 (DISC) 是 R&E 核心的一个关键功能。形成性评估，一个阶段性评估，将纳入 HD2A 内部和之间吸取的经验教训受资助者，提供形成性评估报告（第一年、第三年），重点是提供见解以支持及时决策受资助者和 NIH 进行制定和路线修正，以及最终报告（第 5 年），重点是为未来提供信息我们还将开展 5 个旨在产生此类成果的快速周转研究项目。解决 HD2A 确定的持续或新出现的实施或维持障碍的知识第一年项目将重点关注保险和其他融资的作用。以及广泛采用阿片类药物使用障碍 (MOUD) 药物的报销障碍。在 HD2A 计划内外，我们大胆寻求为戒毒贡献知识和方法和疼痛干预领域，其最终目标是变革和公平的公共卫生利益。